keyword
MENU ▼
Read by QxMD icon Read
search

Non pharmacologic treatment of ADHD

keyword
https://www.readbyqxmd.com/read/27863315/positive-effects-of-transcranial-direct-current-stimulation-in-adult-patients-with-attention-deficit-hyperactivity-disorder-a-pilot-randomized-controlled-study
#1
Carolina Tosetto Cachoeira, Douglas Teixeira Leffa, Suzana Doneda Mittelstadt, Lorenna Sena Teixeira Mendes, Andre R Brunoni, Jairo Vinicius Pinto, Vítor Blazius, Vitoria Machado, Claiton Henrique Dotto Bau, Luis Augusto Rohde, Eugenio Horacio Grevet, Pedro Schestatsky
Almost 30% of adult patients with attention-deficit/hyperactivity disorder (ADHD) do not respond or tolerate standard pharmacological interventions. Few clinical investigations addressed the efficacy and tolerability of transcranial direct current stimulation (tDCS), a non-invasive neuromodulatory technique, in the disorder. We performed a double-blind, sham-controlled randomized clinical trial in 17 patients with ADHD. The set up for tDCS was the following: 2mA/20min/day for 5 days with the anode over the right dorsolateral prefrontal cortex and cathode over the left dorsolateral prefrontal cortex...
November 10, 2016: Psychiatry Research
https://www.readbyqxmd.com/read/27743498/adaptive-skills-are-useful-for-evaluating-the-effect-of-pharmacological-treatment-in-children-with-attention-deficit-hyperactivity-disorder
#2
Ida Lindblad, Salmir Nasic, Magnus Landgren, Leif Svensson, Christopher Gillberg, Elisabeth Fernell
AIM: There are few long-term studies of adaptive functions as an outcome measure of pharmacological treatment in attention-deficit/hyperactivity disorder (ADHD). This study assessed the adaptive abilities of children with ADHD before and after several years of pharmacological treatment. METHOD: We studied 12 children with a mean age of 15 years - seven boys and five girls - who had continued pharmacological treatment for ADHD for more than four years. The Adaptive Behaviour Assessment Scales - Second Edition ratings by their teachers were compared before and after they had received treatment for ADHD...
October 15, 2016: Acta Paediatrica
https://www.readbyqxmd.com/read/27659116/neurofeedback-training-effects-on-inhibitory-brain-activation-in-adhd-a-matter-of-learning
#3
Sarah Baumeister, Isabella Wolf, Nathalie Holz, Regina Boecker-Schlier, Nicoletta Adamo, Martin Holtmann, Matthias Ruf, Tobias Banaschewski, Sarah Hohmann, Daniel Brandeis
Neurofeedback training (NF) is a promising non-pharmacological treatment for ADHD that has been associated with improvement of attention-deficit/hyperactivity disorder (ADHD)-related symptoms as well as changes in electrophysiological measures. However, the functional localization of neural changes following NF compared to an active control condition, and of successful learning during training (considered to be the critical mechanism for improvement), remains largely unstudied. Children with ADHD (N=16, mean age: 11...
September 19, 2016: Neuroscience
https://www.readbyqxmd.com/read/27624381/use-of-psychotropic-drugs-in-patients-with-autism-spectrum-disorders-a-systematic-review
#4
K Jobski, J Höfer, F Hoffmann, C Bachmann
OBJECTIVE: The objective of this review was to examine prevalence and patterns of psychopharmacotherapy in individuals with autism spectrum disorder (ASD). METHOD: A systematic literature search in PubMed, CINAHL, and PsycINFO was performed, including articles published up to November 18, 2015. RESULTS: A total of 47 studies (data collection: 1976-2012), encompassing >300 000 individuals with ASD, were included. The prevalence of psychopharmacotherapy ranged from 2...
September 13, 2016: Acta Psychiatrica Scandinavica
https://www.readbyqxmd.com/read/27453697/a-review-of-pharmacological-management-of-attention-deficit-hyperactivity-disorder
#5
REVIEW
Leslie Briars, Timothy Todd
Attention-deficit/hyperactivity disorder (ADHD) is a common psychological diagnosis in children. This disorder impacts children and adolescents in all areas of life, including academic performance, extracurricular activities, and social interactions. ADHD can continue into adulthood where unemployment and substance abuse has been described. Although behavioral therapy is recommended for all patients with ADHD, medication management typically is initiated soon after diagnosis. Psychostimulants remain the primary medication of choice...
May 2016: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://www.readbyqxmd.com/read/27445873/mindfulness-based-cognitive-therapy-and-the-adult-adhd-brain-a-neuropsychotherapeutic-perspective
#6
Katharina Bachmann, Alexandra P Lam, Alexandra Philipsen
Attention-deficit/hyperactivity disorder (ADHD) is a recognized serious mental disorder that often persists into adulthood. The symptoms and impairments associated with ADHD often cause significant mental suffering in affected individuals. ADHD has been associated with abnormal neuronal activity in various neuronal circuits, such as the dorsofrontostriatal, orbitofrontostriatal, and frontocerebellar circuits. Psychopharmacological treatment with methylphenidate hydrochloride is recommended as the first-line treatment for ADHD...
2016: Frontiers in Psychiatry
https://www.readbyqxmd.com/read/27373215/evaluating-use-of-higher-dose-oxybutynin-in-combination-with-desmopressin-for-refractory-nocturnal-enuresis
#7
Aaron Berkenwald, Jacqueline Pires, Pamela Ellsworth
INTRODUCTION: Nocturnal enuresis is a common pediatric condition with limited treatment options. In older children, pharmacologic therapy is often the preferred treatment. Pharmacologic therapies including desmopressin (DDAVP) or imipramine are effective in 40-50% of children. However, imipramine has serious safety concerns. Desmopressin in combination with a fixed dose anticholinergic has been shown to be useful in individuals who fail desmopressin monotherapy, but still fails to achieve success rates greater than 60%...
August 2016: Journal of Pediatric Urology
https://www.readbyqxmd.com/read/27103462/clinical-and-neurobiological-factors-in-the-management-of-treatment-refractory-attention-deficit-hyperactivity-disorder
#8
Se-Hoon Shim, Hee-Jung Yoon, Jeongjae Bak, Sang-Woo Hahn, Yong-Ku Kim
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent mental disorder of childhood, which often continues into adolescence and adulthood. Stimulants such as methylphenidate (MPH) and non-stimulants such as atomoxetine are effective medications for the treatment of ADHD. However, about 30% of patients do not respond to these medications. Pharmacological treatment for ADHD, although highly effective, is associated with marked variabilities in clinical response, optimal dosage needed and tolerability...
October 3, 2016: Progress in Neuro-psychopharmacology & Biological Psychiatry
https://www.readbyqxmd.com/read/26892760/centrally-acting-non-narcotic-antitussives-prevent-hyperactivity-in-mice-involvement-of-girk-channels
#9
Fumio Soeda, Yoshiko Fujieda, Mizue Kinoshita, Tetsuya Shirasaki, Kazuo Takahama
We have previously reported that centrally acting non-narcotic antitussives inhibited G protein-coupled inwardly rectifying potassium (GIRK) channel-activated currents, and that the antitussives had multiple pharmacological actions on various models of intractable brain diseases in rodents. In this study, the question of whether these antitussives inhibit drug-induced hyperactivity in mice was investigated. Antitussives, such as cloperastine and tipepidine, at cough suppressant doses, inhibited an increase in ambulation of mice neonatally treated with 6-hydroxydopamine...
May 2016: Pharmacology, Biochemistry, and Behavior
https://www.readbyqxmd.com/read/26837866/a-6-year-follow-up-of-a-large-european-cohort-of-children-with-attention-deficit-hyperactivity-disorder-combined-subtype-outcomes-in-late-adolescence-and-young-adulthood
#10
Marloes van Lieshout, Marjolein Luman, Jos W R Twisk, Hanneke van Ewijk, Annabeth P Groenman, Andrieke J A M Thissen, Stephen V Faraone, Dirk J Heslenfeld, Catharina A Hartman, Pieter J Hoekstra, Barbara Franke, Jan K Buitelaar, Nanda N J Rommelse, Jaap Oosterlaan
There are very few studies on the long-term outcome of children and adolescents with ADHD-combined type in Europe. The objective of the present study is to assess the 6-year outcome (including pharmacological treatment) of a large cohort of participants with ADHD-combined type (N = 347, mean age 11.4 years) in late adolescence and early adulthood. At study entry and follow-up (mean age 17.4 years), participants were comprehensively assessed on ADHD and comorbid disorders by structured psychiatric interviews and multi-informant questionnaires...
September 2016: European Child & Adolescent Psychiatry
https://www.readbyqxmd.com/read/26656767/rearing-in-an-enriched-environment-attenuated-hyperactivity-and-inattention-in-the-spontaneously-hypertensive-rats-an-animal-model-of-attention-deficit-hyperactivity-disorder
#11
Chrislean Jun Botanas, Hyelim Lee, June Bryan de la Peña, Irene Joy Dela Peña, Taeseon Woo, Hee Jin Kim, Doug Hyun Han, Bung-Nyun Kim, Jae Hoon Cheong
Attention-deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder, characterized by symptoms of hyperactivity, inattention, and impulsivity. It is commonly treated with psychostimulants that typically begins during childhood and lasts for an extended period of time. However, there are concerns regarding the consequences of chronic psychostimulant treatment; thus, there is a growing search for an alternative management for ADHD. One non-pharmacological management that is gaining much interest is environmental enrichment...
March 1, 2016: Physiology & Behavior
https://www.readbyqxmd.com/read/26599576/methylphenidate-for-children-and-adolescents-with-attention-deficit-hyperactivity-disorder-adhd
#12
REVIEW
Ole Jakob Storebø, Erica Ramstad, Helle B Krogh, Trine Danvad Nilausen, Maria Skoog, Mathilde Holmskov, Susanne Rosendal, Camilla Groth, Frederik L Magnusson, Carlos R Moreira-Maia, Donna Gillies, Kirsten Buch Rasmussen, Dorothy Gauci, Morris Zwi, Richard Kirubakaran, Bente Forsbøl, Erik Simonsen, Christian Gluud
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed and treated psychiatric disorders in childhood. Typically, children with ADHD find it difficult to pay attention, they are hyperactive and impulsive.Methylphenidate is the drug most often prescribed to treat children and adolescents with ADHD but, despite its widespread use, this is the first comprehensive systematic review of its benefits and harms. OBJECTIVES: To assess the beneficial and harmful effects of methylphenidate for children and adolescents with ADHD...
2015: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/26585576/guanfacine-extended-release-a-new-pharmacological-treatment-option-in-europe
#13
REVIEW
Michael Huss, Wai Chen, Andrea G Ludolph
Children/adolescents with attention-deficit/hyperactivity disorder (ADHD) may have a poor or inadequate response to psychostimulants or be unable to tolerate their side-effects; furthermore, stimulants may be inappropriate because of co-existing conditions. Only one non-stimulant ADHD pharmacotherapy, the noradrenaline transporter inhibitor atomoxetine, is currently approved for use in Europe. We review recent advances in understanding of the pathophysiology of ADHD with a focus on the roles of catecholamine receptors in context of the α2A-adrenergic receptor agonist guanfacine extended release (GXR), a new non-stimulant treatment option in Europe...
January 2016: Clinical Drug Investigation
https://www.readbyqxmd.com/read/26446868/efficacy-safety-and-variability-in-pharmacotherapy-for-adults-with-attention-deficit-hyperactivity-disorder-a-meta-analysis-and-meta-regression-in-over-9000-patients
#14
REVIEW
R Cunill, X Castells, A Tobias, D Capellà
RATIONALE: The factors underlying the variability in the results of randomized, placebo-controlled clinical trials (RPCCT) assessing pharmacological interventions for adults with attention deficit hyperactivity disorder (ADHD) are not fully understood. METHODS: A systematic review and meta-analysis of RPCCT comparing pharmacological treatment and placebo in adults with ADHD was carried out. The study outcomes were all-cause treatment discontinuation, efficacy on ADHD symptoms, and safety...
January 2016: Psychopharmacology
https://www.readbyqxmd.com/read/26404187/long-term-pharmacotherapy-of-adults-with-attention-deficit-hyperactivity-disorder-a-literature-review-and-clinical-study
#15
REVIEW
Mats Fredriksen, Dawn E Peleikis
This MiniReview reports and discusses the main findings of the author's thesis including a literature study of long-term pharmacological treatment of adults with attention deficit hyperactivity disorder (ADHD), and a clinical study of 1-year medication. Electronic databases were systematically reviewed for original studies on pharmacotherapy of the defined duration, 24 weeks or more. Although few trials were found with limitations such as excluding comorbidities, treatment with stimulants and atomoxetine was reported tolerated and effective compared to non-treatment...
January 2016: Basic & Clinical Pharmacology & Toxicology
https://www.readbyqxmd.com/read/26386541/attention-deficit-hyperactivity-disorder
#16
REVIEW
Anita Thapar, Miriam Cooper
Attention deficit hyperactivity disorder (ADHD) is a childhood-onset neurodevelopmental disorder with a prevalence of 1·4-3·0%. It is more common in boys than girls. Comorbidity with childhood-onset neurodevelopmental disorders and psychiatric disorders is substantial. ADHD is highly heritable and multifactorial; multiple genes and non-inherited factors contribute to the disorder. Prenatal and perinatal factors have been implicated as risks, but definite causes remain unknown. Most guidelines recommend a stepwise approach to treatment, beginning with non-drug interventions and then moving to pharmacological treatment in those most severely affected...
March 19, 2016: Lancet
https://www.readbyqxmd.com/read/26249301/effect-of-drugs-on-the-risk-of-injuries-in-children-with-attention-deficit-hyperactivity-disorder-a-prospective-cohort-study
#17
Søren Dalsgaard, James F Leckman, Preben Bo Mortensen, Helena Skyt Nielsen, Marianne Simonsen
BACKGROUND: Injuries represent the largest disease burden and most common cause of death in children. Attention deficit hyperactivity disorder (ADHD) is associated with increased mortality, with accidents being the most common cause of death in ADHD. However, it is not known whether pharmacological treatment has any modifying effect on the risk of injuries in children and adolescents with ADHD. METHODS: Using Danish national registers, we followed a cohort of 710 120 individuals, including 4557 individuals diagnosed with ADHD before age 10 years...
August 2015: Lancet Psychiatry
https://www.readbyqxmd.com/read/26233632/pharmacological-management-of-pediatric-patients-with-comorbid-attention-deficit-hyperactivity-disorder-oppositional-defiant-disorder
#18
Daniel F Connor
Attention-deficit hyperactivity disorder (ADHD) is a common developmental neurobiological condition of childhood characterized by age-inappropriate degrees of hyperactivity/impulsivity and inattention to tasks requiring sustained vigilance. Oppositional defiant disorder (ODD) is an externalizing behavior disorder characterized by difficulties with emotional and behavioral regulation that frequently brings the child into conflict with authority figures. In the clinical setting, ODD is the most common ADHD comorbidity...
October 2015: Paediatric Drugs
https://www.readbyqxmd.com/read/26223958/combined-methylphenidate-and-atomoxetine-pharmacotherapy-in-attention-deficit-hyperactivity-disorder
#19
Burcu Ozbaran, Sezen Kose, Onur Yuzuguldu, Burcu Atar, Cahide Aydin
OBJECTIVES: Pharmacological treatment of attention deficit hyperactivity disorder (ADHD) includes stimulant and non-stimulant medications. Our purpose in this study is to investigate efficacy, safety and tolerability of combined methylphenidate and atomoxetine pharmacotherapy. METHODS: We included 12 patients of the 824 patients with ADHD using methylphenidate and atomoxetine combined therapy between the years 2010 and 2014. Kiddie-SADS, Turgay DSM-IV Based Child and Adolescent Behavior Disorders Screening and Rating Scale, Child Behavior Checklist, Clinic Global Impression Scale Severity and Impression (CGIS-S-I) scales were used...
2015: World Journal of Biological Psychiatry
https://www.readbyqxmd.com/read/26189419/-efficacy-of-frequency-neurofeedback-and-cogmed-jm-working-memory-training-in-children-with-adhd
#20
REVIEW
M van Dongen-Boomsma, M A Vollebregt, D Slaats-Willemse, J K Buitelaar
BACKGROUND: The need for and the interest in non-pharmacological treatments for children with ADHD are increasing. The treatments include electro-encephalogram (EEG) frequency-neurofeedback and Cogmed working memory training. AIM: To investigate the efficacy of frequency-neurofeedback and Cogmed working memory training in children with ADHD. METHOD: Forty-one children with ADHD (aged 8-15 years) were assigned to frequency-neurofeedback or to placebo-neurofeedback in a randomized double-blind trial...
2015: Tijdschrift Voor Psychiatrie
keyword
keyword
44086
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"